About Trans-Hit Bio
Trans-Hit Bio is a company based in Laval (Canada) founded in 2009 by Pascal Puchois was acquired by Brooks Automation in December 2020. Trans-Hit Bio operates in a competitive market with competitors including Asterand Bioscience, Pulse Medical Imaging Technology, StageBio, Numira and Numira Biosciences, among others.
- Headquarter Laval, Canada
- Founders Pascal Puchois
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Brooks Automation
(Dec 03, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Trans-Hit Bio
Detailed funding history for Trans-Hit Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Trans-Hit Bio
Trans-Hit Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Brooks Automation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Vacuum robots for semiconductor wafer handling are developed.
|
Locked | Locked | Locked |
Investor details for Trans-Hit Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trans-Hit Bio
Investment portfolio details for Trans-Hit Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Trans-Hit Bio
Detailed financials for Trans-Hit Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Trans-Hit Bio Comparisons
Peer comparison for Trans-Hit Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Trans-Hit Bio
Trans-Hit Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asterand Bioscience, Pulse Medical Imaging Technology, StageBio, Numira and Numira Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human tissue solutions for drug discovery research are supplied globally.
|
|
| Locked | Locked | Locked |
Cardiac imaging services are offered by CRO in Shanghai.
|
|
| Locked | Locked | Locked |
Preclinical pathology services are provided for research and development needs.
|
|
| Locked | Locked | Locked |
Numira is a specialty preclinical CRO specializing in microCT imaging, image analysis, histology, and 3D cancer cell profiling.
|
|
| Locked | Locked | Locked |
Online platform for fast deposits and retail in electronics and fashion categories.
|
|
| Locked | Locked | Locked |
Provider of clinical trials support & software services for medical devices manufacturers
|
Detailed competitors of Trans-Hit Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Trans-Hit Bio
Complete news archive for Trans-Hit Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trans-Hit Bio
Trans-Hit Bio was founded in 2009.
Trans-Hit Bio is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Pascal Puchois is the current CEO of Trans-Hit Bio. They have also founded this company.
Trans-Hit Bio was established in 2009 in Laval, Canada, as a contract research organization (CRO) in the biotechnology sector. Tissue examination services are provided to support pharmaceutical and research needs. Operations are centered on histological analysis and related expertise. The company is led by founder and CEO Pascal Puchois, with its online presence maintained at trans-hit.com.
Trans-Hit Bio's top competitors include Asterand Bioscience, Pulse Medical Imaging Technology and Radiomics.
Trans-Hit Bio has 1 investor. Key investors include Brooks Automation.